Increase In West Pharmaceutical Exposure

In my May 20 West Pharmaceutical (WST) post, I disclosed the purchase of an additional 100 shares @ ~$345.56 in the FFJ Portfolio on May 20 after listening to WST's presentation at BofA's Health Care Conference 2024. Nothing has materially changed following that purchase. WST's share price has, however, experienced subsequent weakness thus leading me [...]

I Will Not Touch TransDigm Group

I will not touch TransDigm Group (TDG) despite it having been an immensely rewarding investment since going public in 2006. Not only is its lofty valuation an area of concern, its liberal use of debt is well beyond my risk tolerance. On occasion, I will invest in a company whose leverage is elevated because it [...]

FFJ Portfolio – May 2024

This FFJ Portfolio - May 2024 report recaps my investment activity during the month. In several recent posts that are accessible through the FFJ Archives, I have disclosed my decision to drastically reduce my exposure to Canadian companies. This will lead to a perfectly acceptable significant reduction in my Canadian dividend income starting in June. [...]

Stop Active Trading!

Heed the advice of Charlie Munger. Stop active trading! The Big Money Is Not In The Buying And The Selling But In The Waiting In my recent Focus On Total Shareholder Return post, I discussed why fixating on dividend metrics to make investment decisions is ridiculous. In this post, I touch upon why you should [...]

Focus On Total Shareholder Return

Some investors make investment decisions based on the number of consecutive years in which a company has increased its dividend and classify companies using the following terminology: Dividend King; Dividend Champion; Dividend Contender; Dividend Achiever; or Dividend Aristocrat I am at a loss as to why dividend metrics should be relevant in the investment decision [...]

Exit The Toronto-Dominion Bank

In my May 13 post, I disclosed that I had exited The Bank of Montreal (BMO), The Bank of Nova Scotia (BNS), and The Canadian Imperial Bank of Commerce (CM). I am now pleased to report that I have exited The Toronto-Dominion Bank (TD). My only remaining exposure to the Canadian banking sector is The [...]

By |May 22nd, 2024|Equity Investing|Comments Off on Exit The Toronto-Dominion Bank

Zoom Video Communications Is Reimagining Teamwork

In my April 10 post, I reviewed Zoom Video Communications' (ZM) FY2024 results and FY2025 guidance. With the release of Q1 2025 results and updated FY2025 outlook following the May 20 market close, I revisit this existing holding. Business Overview I recommend you review Part 1, Item 1 in ZM's FY2024 Form 10-K which provides [...]

By |May 21st, 2024|Equity Investing|Comments Off on Zoom Video Communications Is Reimagining Teamwork

West Pharmaceutical – Investing Heavily For Future Growth

I last reviewed West Pharmaceutical (WST) in this April 29 post at which time I disclosed my intent to purchase an additional 50 shares in a 'Core' account within the FFJ Portfolio; I did acquire another 50 shares on April 29 @ ~$357.54 thereby bringing my exposure to 200 shares. Not much has changed since [...]

By |May 20th, 2024|Equity Investing|Comments Off on West Pharmaceutical – Investing Heavily For Future Growth

Copart – A Wonderful Wide Moat Company

The Canadian Federal government's 2024 Budget proposes to: increase the capital gains inclusion rate for capital gains realized on and after June 25, 2024, from 50% to 66.67% for corporations and trusts; and from 50% to 66.67% on the portion of capital gains realized in the year that exceed $250,000 for individuals. This change in [...]

By |May 17th, 2024|Equity Investing|Comments Off on Copart – A Wonderful Wide Moat Company
Go to Top